Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre,... by Mell, Loren K, Prof, Torres-Saavedra, Pedro A, PhD, Wong, Stuart J, Prof, Kish, Julie A, Prof, Chang, Steven S, MD, Jordan, Richard C, Prof, Liu, Tian, PhD, Truong, Minh Tam, Prof, Winquist, Eric W, Prof, Takiar, Vinita, MD PhD, Wise-Draper, Trisha, MD PhD, Robbins, Jared R, Prof, Rodriguez, Cristina P, Prof, Awan, Musaddiq J, MD, Beadle, Beth M, MD PhD, Henson, Christina, MD, Narayan, Samir, MD, Spencer, Sharon A, Prof, Powell, Steven, MD, Dunlap, Neal, Prof, Sacco, Assuntina G, MD, Hu, Kenneth Shung, Prof, Park, Henry S, MD MPH, Bauman, Julie E, Prof, Harris, Jonathan, MS, Yom, Sue S, Prof, Le, Quynh-Thu, MD

Get full text

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall surviv... by Ryan, Charles J, Prof, Smith, Matthew R, Prof, Fizazi, Karim, Prof, Saad, Fred, Prof, Mulders, Peter F A, Prof, Sternberg, Cora N, MD, Miller, Kurt, Prof, Logothetis, Christopher J, Prof, Shore, Neal D, MD, Small, Eric J, Prof, Carles, Joan, MD, Flaig, Thomas W, MD, Taplin, Mary-Ellen, MD, Higano, Celestia S, Prof, de Souza, Paul, Prof, de Bono, Johann S, Prof, Griffin, Thomas W, MD, De Porre, Peter, MD, Yu, Margaret K, MD, Park, Youn C, PhD, Li, Jinhui, PhD, Kheoh, Thian, PhD, Naini, Vahid, PharmD, Molina, Arturo, MD, Rathkopf, Dana E, MD

Get full text